Challenges and pitfalls of extracorporeal membrane oxygenation in critically-ill pregnant and peripartum women with COVID-19: a retrospective case series
Authors' conclusion
ECMO is feasible in the third trimester but not devoid of complications. The severity of respiratory failure during COVID-19 and extracorporeal support may not adversely impact neonatal outcomes.
Study context
- Population
- Pregnant and peripartum women with COVID-19 ARDS supported with extracorporeal membrane oxygenation (ECMO) and anticoagulated with anti-Xa-guided nadroparin
- Participants
- 5 participants
- Outcome
- Maternal and neonatal outcomes
Methodological detailssingle-centre
- Single-centre
Main finding
As reported in the abstract
Newborns surviving to hospital discharge
4 of 5
Mothers surviving to hospital discharge
2 of 5
ARDS due to COVID-19 in third trimester
5 of 5
Termination of pregnancy, gestational weeks
28–36
Observational data: associations, not effects.
Original publication
Challenges and pitfalls of extracorporeal membrane oxygenation in critically-ill pregnant and peripartum women with COVID-19: a retrospective case series. Int J Obstet Anesth. Published 4 January 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →